A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas by Lee, J K, Capanu, M, O'Reilly, E M, Ma, J, Chou, J F, Shia, J, Katz, S S, Gansukh, B, Reidy-Lagunes, D, Segal, N H, Yu, K H, Chung, K-Y, Saltz, L B, Abou-Alfa, G K

Get full text

Antidepressant Use in Patients with Carcinoid Tumors: Results of A Systematic Review by Isenberg-Grzeda, E, Macgregor, M, Matsoukas, K, Reidy-Lagunes, D, Alici, Y

Get full text

Retrospective Chart Review of Antidepressant Use in Patients with Carcinoid Tumors by Isenberg-Grzeda, E, Macgregor, M, Bergel, A, Eagle, S, Espi-Forcen, F, Mehta, R, Matsoukas, K, Wills, J, Reidy-Lagunes, D, Alici, Y

Get full text

232TiP Lanreotide autogel/depot in lung neuroendocrine tumours: The randomized double-blind placebo-controlled international phase 3 SPINET Study by Thanh, X-M. Truong, Reidy-Lagunes, D., Kulke, M., Wolin, E., Singh, S., Ferone, D., Hoersch, D., Houchard, A., Caplin, M., Baudin, E.

Get full text

Cytological features contributing to the misclassification of pancreatic neuroendocrine tumors by Sigel, Carlie, MD, Reidy-Lagunes, Diane, MD, Lin, Oscar, MD, PhD, Basturk, Olca, MD, Aggarwal, Gitika, MD, Klimstra, David S., MD, Tang, Laura, MD, PhD

Get full text

Lanreotide autogel/depot in lung neuroendocrine tumours: The randomized, double-blind, placebo-controlled, international phase 3 SPINET Study: 232TiP by Thanh, X-M Truong, Reidy-Lagunes, D, Kulke, M, Wolin, E, Singh, S, Ferone, D, Hoersch, D, Houchard, A, Caplin, M, Baudin, E

Get full text

Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy by Cercek, Andrea, Dos Santos Fernandes, Gustavo, Roxburgh, Campbell S, Ganesh, Karuna, Ng, Shu, Sanchez-Vega, Francisco, Yaeger, Rona, Segal, Neil H, Reidy-Lagunes, Diane L, Varghese, Anna M, Markowitz, Arnold, Wu, Chao, Szeglin, Bryan, Sauvé, Charles-Etienne Gabriel, Salo-Mullen, Erin, Tran, Christina, Patel, Zalak, Krishnan, Asha, Tkachuk, Kaitlyn, Nash, Garrett M, Guillem, Jose, Paty, Philip B, Shia, Jinru, Schultz, Nikolaus, Garcia-Aguilar, Julio, Diaz, Luis A, Goodman, Karyn, Saltz, Leonard B, Weiser, Martin R, Smith, J Joshua, Stadler, Zsofia K

Get full text

Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan by Reidy-Lagunes, Diane, Pandit-Taskar, Neeta, O'Donoghue, Joseph A., Krebs, Simone, Staton, Kevin D., Lyashchenko, Serge K., Lewis, Jason S., Raj, Nitya, Gönen, Mithat, Lohrmann, Christian, Bodei, Lisa, Weber, Wolfgang A.

Get full text

Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177 Lu-Satoreotide Tetraxetan by Reidy-Lagunes, Diane, Pandit-Taskar, Neeta, O'Donoghue, Joseph A, Krebs, Simone, Staton, Kevin D, Lyashchenko, Serge K, Lewis, Jason S, Raj, Nitya, Gönen, Mithat, Lohrmann, Christian, Bodei, Lisa, Weber, Wolfgang A

Get full text

Abstract 3735: Somatostatin receptor-based imaging and treatment of murine pancreatic neuroendocrine tumors induced by MEN1-loss by Li, Janet W., Zhang, Hanwen, Carlin, Sean D., Raj, Nitya, Klimstra, David S., Libutti, Steven K., Weber, Wolfgang A., Reidy-Lagunes, Diane, Untch, Brian R.

Get full text

Urinary Neuroendocrine Neoplasms Treated in the “Modern Era”: A Multicenter Retrospective Review by Le, Bryan Khuong, McGarrah, Patrick, Paciorek, Alan, Mohamed, Amr, Apolo, Andrea B., Chan, David L., Reidy-Lagunes, Diane, Hauser, Haley, Rivero, Jaydira D., Whitman, Julia, Batty, Kathleen, Zhang, Li, Raj, Nitya, Le, Tiffany, Bergsland, Emily, Halfdanarson, Thorvardur R.

Get full text

SUN-911 Immunotherapy Use in Adrenocortical Carcinoma with Encouraging Results- a Case Report by Madhavan, Parvathy, Shichman, Steven, Raj, Nitya, Reidy-Lagunes, Diane L, Malchoff, Carl D

Get full text